Immunocore Holdings PLC (IMCR)
32.28
+0.16
(+0.50%)
USD |
NASDAQ |
Nov 22, 16:00
32.22
-0.06
(-0.19%)
After-Hours: 20:00
Immunocore Holdings Price to Book Value: 4.275 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 22, 2024 | 4.275 |
November 21, 2024 | 4.253 |
November 20, 2024 | 4.293 |
November 19, 2024 | 4.312 |
November 18, 2024 | 4.112 |
November 15, 2024 | 4.183 |
November 14, 2024 | 4.320 |
November 13, 2024 | 4.525 |
November 12, 2024 | 4.469 |
November 11, 2024 | 4.587 |
November 08, 2024 | 4.594 |
November 07, 2024 | 4.543 |
November 06, 2024 | 4.438 |
November 05, 2024 | 4.369 |
November 04, 2024 | 4.128 |
November 01, 2024 | 4.198 |
October 31, 2024 | 4.083 |
October 30, 2024 | 4.225 |
October 29, 2024 | 4.331 |
October 28, 2024 | 4.413 |
October 25, 2024 | 4.343 |
October 24, 2024 | 4.303 |
October 23, 2024 | 4.240 |
October 22, 2024 | 4.410 |
October 21, 2024 | 4.410 |
Date | Value |
---|---|
October 18, 2024 | 4.552 |
October 17, 2024 | 4.469 |
October 16, 2024 | 4.405 |
October 15, 2024 | 4.279 |
October 14, 2024 | 4.262 |
October 11, 2024 | 4.116 |
October 10, 2024 | 4.090 |
October 09, 2024 | 3.972 |
October 08, 2024 | 4.048 |
October 07, 2024 | 4.071 |
October 04, 2024 | 4.119 |
October 03, 2024 | 4.038 |
October 02, 2024 | 4.116 |
October 01, 2024 | 4.132 |
September 30, 2024 | 4.122 |
September 27, 2024 | 4.373 |
September 26, 2024 | 4.286 |
September 25, 2024 | 4.270 |
September 24, 2024 | 4.187 |
September 23, 2024 | 4.290 |
September 20, 2024 | 4.621 |
September 19, 2024 | 4.765 |
September 18, 2024 | 4.797 |
September 17, 2024 | 4.721 |
September 16, 2024 | 4.596 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.588
Minimum
Jan 20 2022
31.59
Maximum
Feb 08 2021
7.645
Average
7.021
Median
Oct 13 2022
Price to Book Value Benchmarks
Adaptimmune Therapeutics PLC | 2.116 |
Biodexa Pharmaceuticals PLC | 0.2405 |
Verona Pharma PLC | 24.34 |
NuCana PLC | 0.5749 |
Autolus Therapeutics PLC | 1.640 |
Price to Book Value Related Metrics
PS Ratio | 5.508 |
Price to Free Cash Flow | 82.13 |
Price | 32.28 |
Earnings Yield | -2.94% |
Market Cap | 1.615B |